🇺🇸 FDA
Patent

US 7205005

Medicament containing epidemium extract for treatment of prostatic hyperplasia and prostatitis

granted A61KA61K36/00A61K36/258

Quick answer

US patent 7205005 (Medicament containing epidemium extract for treatment of prostatic hyperplasia and prostatitis) held by Bright Future Pharmaceutical Laboratories expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Bright Future Pharmaceutical Laboratories
Grant date
Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K36/00, A61K36/258, A61K36/296, A61K36/481